Human Trials for HIV Vaccine Made With mRNA Technology to Begin
Over the past decade, advances in HIV treatment have yielded new drug combinations, once-daily dosing, and, most recently, the introduction …
Home »
New Guideline for Replacement ART: CAB/RPV LA Not for Everyone
“One of the most important considerations before switching HIV patients to injectable long-acting cabotegravir/rilpivirine [CAB/RPV LA; Cabenuva, ViiV Healthcare] is …
Syphilis in MSM 15 Times Higher Than General Population
Worldwide, nearly 8% of men who have sex with men (MSM) may have syphilis, a new systematic review and meta-analysis …
HIV Generic Drug for Babies Distributed in Africa, Says UNITAID
DUBAI (Reuters) – Aid agencies have distributed a strawberry-flavoured tablet for children living with HIV in six African countries, the …
AI app could help diagnose HIV more accurately
Pioneering technology developed by UCL and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV …
How Patent Extensions Keep Some Drug Costs High
Priti Krishtel’s first case as a legal aid lawyer in India was as tragic as they come. One day in 2004, …
Experts See Strides on AIDS, but COVID-19 Halted Progress
Some researchers believe COVID-19 has derailed the fight against HIV, siphoning away health workers and other resources and setting back …
Change to Gilead Assistance Program Threatens PrEP Access
Dr. John Carlo is concerned that patients at Prism Health North Texas who rely on the health care safety net …
Mobile gaming app enhances HIV care
Researchers at the University of North Carolina at Chapel Hill and Duke University improved HIV care by gamifying it with …
Four in ten transgender women have HIV
(HealthDay)—Four in 10 transgender women have HIV, which shows the urgent need to offer them more prevention and treatment services, …
HIV: An antidiabetic drug to reduce chronic inflammation
Metformin, a drug used to treat type-2 diabetes, could help reduce chronic inflammation in people living with HIV (PLWH) who …
Universal ‘test and trace’ for HIV cost-effective in high prevalence regions
Rolling out home-based testing and universal treatment for HIV is cost-effective and can cut the incidence of cases in high-prevalence …
Universal ‘test and trace’ for HIV cost-effective in high prevalence regions
Rolling out home-based testing and universal treatment for HIV is cost-effective and can cut the incidence of cases in high-prevalence …
Zeklen
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZEKLEN® Ezetimibe/Simvastatin Consumer Medicine Information What is …
Viramune XR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VIRAMUNE XR CMI0135-06 Extended-Release Tablets nevirapine Consumer …
Kalma
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KALMA contains the active ingredient alprazolam CONSUMER …
HIV in Australia has declined by 12% in the past five years
New HIV data, released today by the Kirby Institute at UNSW Sydney for World AIDS Day, are a reminder for …
Millions of people are on treatment for HIV: Why are so many still dying?
Twenty years ago, treatment for HIV was a rare luxury in South Africa. Exorbitant costs and President Thabo Mbeki’s government’s …